Last reviewed · How we verify

TAS-205, [14C]TAS-205

Taiho Pharmaceutical Co., Ltd. · Phase 1 active Small molecule

TAS-205, [14C]TAS-205 is a Small molecule drug developed by Taiho Pharmaceutical Co., Ltd.. It is currently in Phase 1 development.

At a glance

Generic nameTAS-205, [14C]TAS-205
SponsorTaiho Pharmaceutical Co., Ltd.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about TAS-205, [14C]TAS-205

What is TAS-205, [14C]TAS-205?

TAS-205, [14C]TAS-205 is a Small molecule drug developed by Taiho Pharmaceutical Co., Ltd..

Who makes TAS-205, [14C]TAS-205?

TAS-205, [14C]TAS-205 is developed by Taiho Pharmaceutical Co., Ltd. (see full Taiho Pharmaceutical Co., Ltd. pipeline at /company/taiho-pharmaceutical-co-ltd).

What development phase is TAS-205, [14C]TAS-205 in?

TAS-205, [14C]TAS-205 is in Phase 1.

Related